MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia
Results presented by the LiBBY study team at the Alzheimer’s Association International Conference ("AAIC”) demonstrated statistically significant improvements in agitation symptoms compared with…
Read the full articleYou might also wanna read
Xi to present China's AI dream at major conference
Manila Times·24m ago
Ohmyhome Ltd Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Manila Times·30m ago
Pele's World Cup jersey fetches $4.9 million at US auction
Manila Times·34m ago
Cycurion Receives Nasdaq Delisting Determination Letter; Appeal Underway, Trading to Continue, Focus on Shareholder Value
Manila Times·36m ago
Capstone Infrastructure Corporation Reports Results of Exercise of Conversion Rights for Cumulative 5-Year Rate Reset Preferred Shares, Series A
Manila Times·36m ago
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
Manila Times·36m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.